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This study sought to examine changes in psychological distress following cancer genetic counselling. Women attending a family
cancer clinic completed questionnaires before their appointment and at 2 weeks, 6 months and 12 months after their
appointment. Twenty-six women were at low risk of developing breast or ovarian cancer, 76 were at moderate risk, 46 were
at high risk and 46 women had previously had breast or ovarian cancer. All groups were compared with regard to measures
of anxiety, depression, general psychological distress, worry about developing breast and ovarian cancer, and perceived risk of
developing breast/ovarian cancer and perceived likelihood of carrying a genetic mutation. General psychological distress did
not change over the course of the study and the groups did not differ on these measures. Worry about developing breast
cancer and perceptions of the likelihood of carrying a genetic mutation significantly reduced following genetic counselling. On
the whole women who had already had breast/ovarian cancer showed more concerns about ovarian cancer and raised
perceptions of risk in comparison with the other groups, indicating the need for sensitive counselling of such women.
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The population risk of developing breast cancer in the UK is one in
12 and the risk of ovarian cancer is one in 100. A small proportion
(approximately 5 – 10%) of women who develop breast and ovarian
cancers have an inherited genetic susceptibility to these cancers
(Claus et al, 1991; Easton and Peto, 1990). To date, two breast
and ovarian cancer predisposing genes have been identified –
BRCA1 (Miki et al, 1994; Easton et al, 1995; Narod et al, 1995),
and BRCA2 (Wooster et al, 1995). Women who have inherited a
mutation in the BRCA1 or BRCA2 gene have approximately an
80% risk of developing breast cancer over their lifetime, particu-
larly at a young age, and a 40 – 60% lifetime risk of ovarian
cancer (Easton et al, 1995).
Widespread publicity about the possible genetic basis of some
breast and ovarian cancers has lead to an increase in concern
amongst women with a family history of these cancers. In many
cases this concern may be unfounded, as the vast majority of these
cancers are not due to an inherited genetic predisposition.
However, increasing numbers of women are attending clinics in
hospitals in the UK for genetic counselling about their family
history of breast or ovarian cancer where most will want informa-
tion about their future risk of developing cancer (Brain et al,
2000a) and about what steps they can take to minimize this risk.
A further motivation for attending for genetic counselling is to
undergo genetic testing.
Psychological distress
Relevant psychological issues have been raised and discussed
regarding hereditary breast cancer (Lerman and Croyle, 1994).
Studies have used different assessment tools for measuring
psychological distress and therefore apparent prevalence rates
for distress vary (Hopwood et al, 1998). A variety of measures
are used; some are specific to anxiety or depression (e.g. Hospi-
tal Anxiety and Depression Scale: Zigmond and Snaith (1983);
Beck Depression Inventory: Beck and Steer (1987), State-Trait
Anxiety Inventory: Spielberger et al (1983), others assess more
general psychiatric distress (e.g. General Health Questionnaire:
Goldberg and Williams (1988), and others are cancer specific,
or can be adapted to be so (Cancer Worry Scale: Lerman et al
(1991); Impact of Events Scale: Horowitz et al (1979). Compar-
ison between samples is difficult as inclusion criteria vary.
Research in the USA has found that relatives of breast cancer
patients, who are therefore at increased risk themselves, may
suffer psychological distress (Kash et al, 1992; Wellisch et al,
1991). Twenty-seven per cent of the women in the study carried
out by Kash et al (1992) were suffering psychological distress
that warranted psychological counselling – although how this
was assessed is not stated. Some studies in the UK and USA
have found that levels of anxiety and general distress among
women at risk are higher than those found in the general popu-
lation (e.g. Cull et al, 1999; Lerman et al, 1994; Valdimarsdottir
et al, 1995) although no higher than among women attending
for screening.
Raised levels of distress can have detrimental effects. Women
attending for genetic counselling are given information about risk
and surveillance behaviours and also possible genetic testing.
Women who are distressed may fail to take in this information
(Hopwood et al, 1998; Cull et al, 1999) and act on it appropriately
(Lerman et al, 1995). In addition, high anxiety may diminish
women’s willingness to participate in screening and surveillance
(Kash et al, 1992; Lerman et al, 1993) or lead to excessive self
examination (Brain et al, 1999).
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Some of the few prospective studies that have examined how
genetic counselling may influence levels of distress have found that
general distress (Cull et al, 1999; Brain et al, 2000b) and cancer
specific worry (Brain et al, 2000b; Kent et al, 2000) reduce follow-
ing counselling, although others found no change (Watson et al,
1999). However, the group in the study by Watson et al (1999)
were not split on the basis of their actual risk of developing cancer
which may be likely to influence level of worry.
The current study
The current study improves on previous research in that it includes
women who have already had and been treated for breast or ovar-
ian cancer (‘affected’ women) who make up a significant
proportion of those being counselled, in addition the study classi-
fies unaffected women in terms of their actual risk of developing
breast cancer. Evaluation of the psychological effects of genetic
counselling among affected women has been relatively neglected
in the literature on psychological distress. The assumption seems
to be that these women will be less distressed and worried in the
face of being at increased risk as they have already had cancer
and therefore received the ‘worst possible news’. The current study
explores whether these women are in fact less distressed and
worried than unaffected women. In recent years the counselling
offered to affected women has increased considerably due to a
changing emphasis from research to service and is now broadly
similar to that offered to unaffected women. However, it does
differ. Women who have already had cancer are counselled that,
if they have a genetic predisposition to cancer, their chance of
developing a second primary cancer would be increased. However,
specific risk figures are not usually given (for women who have
already had breast cancer the lifetime risk of developing ovarian
cancer can be estimated based on the family history. Similarly,
for women who have already had ovarian cancer the lifetime risk
of developing breast cancer can be estimated based on family
history). Unaffected women, on the other hand, are given an esti-
mate of their future risk of developing cancer, with reference to
epidemiological data (Claus et al, 1991). Current UK guidelines
suggest that women estimated to have a greater than a 1 in 3
chance of developing breast cancer are at ‘high’ risk; between 1
in 6 and 1 in 4 are at ‘moderate’ risk and less than 1 in 6 are at
‘low’ risk (Eccles et al, 2000). It is predicted in this study that these
four groups of women may differ for changes in psychological
distress and worry following counselling. For example, women
who are told at the first consultation that they are not at increased
risk of breast cancer will show a greater reduction in specific worry
about cancer than those at moderate or high risk or affected
women.
The current study also assesses worry about developing ovarian
cancer amongst women attending for genetic counselling. This is
rarely assessed despite the fact that if women have a BRCA1 or
BRCA2 mutation they are at a greatly increased lifetime risk of
developing ovarian cancer. It is expected that this is not widely
known by women before attending for genetic counselling. As
ovarian cancer is less common than breast cancer, it is anticipated
that women will be less worried about developing it than they are
about developing breast cancer, but that group differences may
show post-consultation once women have been informed that they
may be at risk of ovarian cancer as well. For example, low risk
women may be less worried than high risk women.
The main focus of this study is on psychological distress and
worry, however, perceptions of risk are also relevant. There is some
evidence that women attending for genetic counselling overestimate
their risk of developing breast cancer before their consultation
(Lerman et al, 1995). In contrast, Cull et al (2001) found that
women were in fact more likely to underestimate their risk of
developing ovarian cancer than to overestimate it. It is difficult
to predict how risk perceptions may change following genetic
counselling as this would depend on what women are told about
their risk and also on how accurate their perceptions are before-
hand. It is not the aim of the current study to assess accuracy of
perceptions. However risk perceptions are being examined as a
variable that may change following genetic counselling and which
may be related to changes in worry and distress.
The aims of the current study therefore are to identify levels of
distress and worry in women before they attend a genetic counsel-
ling clinic, to compare levels amongst affected and unaffected
women (at differing levels of risk); to look at changes in distress
and worry over time and differences among groups for any
changes.
METHOD AND MEASURES
Patients were recruited into the study at the Department of Clinical
Genetics at Guy’s Hospital between May 1997 and May 1999.
Criteria for referral are shown in Table 1. Recruitment was slower
than expected and there was insufficient time to follow up all
women until 12 months after their first consultation, consequently
the numbers of women contacted at each time point varies. All
women listed on the clinic database as due to attend their first
genetic counselling appointment (n=577) were sent a questionnaire
prior to this appointment and 412 women returned a completed
questionnaire. However, 121 of the women who were sent an
appointment failed to attend for this (a non-attendance rate of
21% which is in keeping with other clinics). The response rate
to the questionnaire among attenders at the clinic was 86% (393
out of 456). At their consultation, all women were asked to parti-
cipate in the research by completing questionnaires. Women were
asked to participate regardless of whether or not they had
completed the first questionnaire. In addition, some women
attended the clinic unexpectedly with a relative, and so had not
been sent a questionnaire previously as they had not been sent
an appointment (n=69). As these women were also at risk, or
had been affected with cancer, effort was made to include them
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Table 1 Referral criteria
Individual history
* Breast cancer diagnosed 540 years old
* More than one breast cancer primary
* Breast and ovarian cancer presenting as two primaries.
Family history
* Three close relatives (same side of the family) with breast or ovarian cancer
* Two close relatives (same side of the family) with breast or ovarian cancer with at least one relative diagnosed 550 years old
* One first degree relative with breast cancer diagnosed 540 years old
* One first degree relative with bilateral breast cancer/two primaries in the same breast/breast and ovarian cancer.
Other
* Patients who are very worried about their family history but who do not fit the above criteria are also seen.
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from this stage onwards. Of the 525 women who attended the
clinic during the study period 96% (505 out of 525) agreed to take
part in the research and 83% of these returned a completed ques-
tionnaire in the 2 weeks following their appointment (421 out of
505). Six months later 362 women were recontacted and sent a
further questionnaire. Eight-five per cent (308 out of 362) were
returned. Six months after this (12 months post consultation)
the final questionnaire for the study was sent to 270 women and
91% (246 out of 270) were completed. For the purposes of this
study only women who had completed all four questionnaires
(pre-consultation, 2 week, 6 months and 12 months post consulta-
tion) are included in the following analyses (n=203).
The 203 women had a mean age of 42.3 years (s.d. 12.6, range
18 – 79 years). Most (73%) had a partner at the time of the study
and the majority (73%) had at least one child. Ninety-seven per
cent of the women classified themselves as white. Most (70%) of
the women currently worked outside the home.
Genetic counselling
Women with a family history of breast/ovarian cancer who attend
the family cancer clinic are either seen by a doctor (a consultant
clinical geneticist or a specialist registrar in genetics) or a genetic
counsellor (graduate nurses or science graduates with training in
genetic counselling) for non-directive counselling. The sessions take
between 45 min and 112 h. Prior to attending the clinic women will
have completed a family history sheet detailing the number of cases
of cancer in their family, the type of cancer, the relationship of the
person to the women, the age at diagnosis and death (if applic-
able). During the consultation a more detailed family history is
taken. Using this information the woman’s personal risk of devel-
oping breast cancer is calculated. At the time of this research the
method used for risk assessment was the CASH model (Claus et
al, 1991) which provides a risk estimate based on the number of
breast cancer cases in first and second degree relatives, the age at
diagnosis and the age of the woman. The basis of genetic inheri-
tance is explained to women and the implication of genetic
testing is discussed if appropriate. Options for screening and
surveillance are also explained.
Groups
Forty-six (24%) of the women had previously had breast and/or
ovarian cancer (referred to in this study as ‘affected’ women): 41
had had breast cancer, one woman had had ovarian cancer and
four women had had both. The mean time since diagnosis of breast
cancer was 5 years (range 4 months to 32 years) and for ovarian
cancer the mean time was 4 years (range 6 months to 13 years).
One hundred and fifty-seven women were unaffected and had
not previously had cancer. For the purposes of this study these
women were classified into three risk groups (based on the current
UK guidelines) using the risk estimate that was written in their
hospital notes. Women had been told this figure and what it meant
during their consultation. Twenty-six women (13.4%) were classi-
fied as at low risk (lifetime risk of developing breast cancer less
than 1 in 6), 76 (39.2%) were classified as at moderate risk (life-
time risk of developing breast cancer between 1 in 6 and 1 in 4
inclusive) and 46 (23.7%) were classified as at high risk (lifetime
risk of 1 in 3 or higher). Data were missing for nine women
who are not, therefore, included in the following analyses of
variance. Six of these women had not been given a breast cancer
risk estimate at the clinic as their family history data was incom-
plete (n=2) or they had a family history of ovarian cancer only
and their risk of developing breast cancer was therefore difficult
to estimate (n=4). Files were missing for three women and there-
fore their risk could not be confirmed. The four groups of
women: affected, low risk, moderate risk and high risk will be
compared in the following analyses. (Forty-eight (24%) women
underwent genetic testing in the course of the study: 39 affected
women had blood taken to search for a BRCA1/2 mutation and
nine unaffected high risk women underwent predictive testing.
All had received a test result at 6 months post-consultation,
although for the affected women this was a result for screening
only part of the BRCA1 gene, and 37 received a result at this time
stating that nothing had been found. A mutation was found in
eight women and three women received a negative result on a
predictive test.) With this sample size (n=203), power calculations
showed good power to detect differences of any clinically meaning-
ful magnitude in the variables examined in the study. For example,
a sample size of 203 gives 90% power, at a 5% significance level, to
detect a difference of 2.3 in breast cancer worry between two of the
four groups. The power for comparisons between times will be
even greater because of the within-subjects design.
Measures
To assess psychological distress and worry three general and one
specific measure were used. The Hospital Anxiety and Depression
Scale (HADS; Zigmond and Snaith, 1983) gives separate measures
of anxiety and depression assessed over the last week (range of scores
from 0 to 21, seven items for anxiety and seven for depression). The
short form of Spielberger’s state-trait anxiety scale (STAI; Marteau
and Bekker, 1992) was also used. This scale includes six items asking
women to report their current anxiety state (range of scores from 6 to
24). The 28 item version of the General Health Questionnaire (GHQ-
28; Goldberg and Williams, 1988) was used as a general measure of
psychological distress (range of scores from 0 to 84). For the main
analyses this continuous measure was used. However, for descriptive
purposes the scale was also scored using the GHQ-scoring method
and a score of 5 was taken as a cut off for case/non-case. A higher
cut off of a score of 10 was also used as suggested by Hopwood et
al (1998) for high risk women. Cronbach alpha reliabilities for the
four time points in this sample for these three general measures were
all greater than 0.82.
A scale designed to assess specific worry about developing cancer
was used (Cancer Worry Scale; Lerman et al, 1991). This was adapted
to create a scale assessing breast cancer worry and a separate scale to
assess worry about developing ovarian cancer. (Women who had had
their ovaries removed did not complete the worry about ovarian
cancer scale (n=10). The scales each include six items scored from
1 to 4 with labelled response categories, giving a possible range of
scores of 6 – 24. The scale includes items to assess how worry about
developing cancer has affected mood and activities in the last month,
and the frequency and intensity of worry. Women who had already
had cancer were asked to specify their worry about developing cancer
again. Cronbach alpha reliabilities for the scale at the four time points
were greater than 0.82.
In addition, two measures of perceived risk were used. One
assessed perceptions about breast cancer risk relative to other
women of their age (scored on a 5 point Likert type scale,
responses from 72 (much less likely) to 2 (much more likely)).
Some research (e.g. Woloshin et al, 1999) suggests that such items
lead to the most accurate assessment of women’s perceived risk in
comparison to, for example, asking women to express their
perceived risk in terms of a 1 in ? chance. The second assessed
perceived likelihood that they carried a mutation (scored on a 5
point Likert type scale, responses from 72 (extremely unlikely)
to 2 (extremely likely)).
RESULTS
Missing data
Independent t-tests and w2-tests were used to compare demo-
graphic details and baseline psychological distress and worry
measures in women who did not complete questionnaires up
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to 12 months post-consultation with the 203 women who
completed all questionnaires to check for generalizability of
results. The main reason for incomplete data was lack of time
in the study period to follow up all women to 1 year after their
consultation, rather than it being non-response to the question-
naires. No differences were found for any of the psychological
measures. However, some demographic differences were found.
Women with incomplete data were younger than those with
complete data (t(418)=2.93, P50.01). They were also less likely
to have a partner (w2=19.7, P50.001) or to have any children
(w2=3.9, P50.05). These demographic differences are likely to
be connected to one another. In addition, a higher proportion
of affected women had incomplete data (w2=4.6, P50.05).
Description of sample: Psychological distress and worry
pre-consultation (baseline)
Prior to genetic counselling the mean score for women’s levels of
anxiety as measured by the HADS was 6.7 (s.d. 4.0) and for
depression it was 3.0 (s.d. 2.9). Taking scores above 8 as a cut
off for possible anxiety or depression disorder, 41% of the
sample scored above this on the anxiety subscale and 11% did
so on the depression subscale. These mean HADS scores are
comparable to those found in other studies of women under-
going genetic counselling for breast/ovarian cancer risk (e.g.
DudokdeWit et al, 1998; Kent et al, 2000; Lodder et al, 1999)
and for women undergoing routine breast screening (Walker et
al, 1994). Mean GHQ-28 scores were 21.2 (s.d. 11.5). Thirty-
one per cent of women could be classified as ‘cases’ on this
scale, which is comparable to proportions found by Cull et al
(1999, 2001) and Watson et al (1999) amongst their samples
of women undergoing genetic counselling. Using the higher
threshold advocated by Hopwood et al (1998), only 16% of
women could be classified as cases. Mean STAI scores were
11.3 (s.d. 4.2).
The pre-consultation mean score for worry about breast cancer
was 12.4 (s.d. 3.4) and for worry about ovarian cancer it was 8.3
(s.d. 2.9), levels comparable to those found by Brain et al (1999)
among women at risk of breast cancer. Thirty-four per cent of
women reported that they worry often or almost all the time about
developing breast cancer whereas only 7% reported these feelings
about ovarian cancer. A paired t-test showed that, as predicted,
there was significantly less worry about ovarian cancer than breast
cancer pre-consultation (t=15.1(188), P50.0001). This difference
persisted at 2 weeks (t=12.8(188), P50.0001), 6 months
(t=12.1(188), P50.0001) and 12 months post consultation
(t=10.0(188), P50.0001).
The mean score for perceptions of risk of developing breast
cancer was 1.2 (s.d. 0.75) and for likelihood of carrying a mutation
it was 0.8 (s.d. 0.85). Examining these variables in terms of propor-
tions of women endorsing the given options, 47% of women felt
that their risk was slightly higher than other women and a further
36% felt it was much higher. For perceived likelihood of carrying a
mutation, 43% of the women felt this was fairly likely and 20%
extremely likely.
Comparison between affected and unaffected women (split
by risk) for levels of, and changes in, psychological distress
Repeated measures analyses of variance (ANOVAs) were carried
out to examine changes over time in anxiety, depression, general
distress levels, specific worry about developing cancer and
perceptions of risk and also to examine whether the groups
differed on these measures. Group means (s.d.) at each of the
four time points are shown in Table 2. Results of the ANOVA
are shown in Tables 3 and 4 and Figures 1 and 2. Supplemen-
tary analyses were also carried out to clarify the significant
findings.
General measures (HADS, STAI, GHQ-28) No significant
changes were found in levels of general anxiety, depression, or
psychological distress over the 12 month study period. In addition,
the groups did not differ on these measures and there were no
significant interaction effects (Table 3).
Worry about breast cancer For the sample as a whole, there was
a significant reduction in worry about breast cancer over the course
of the study (Table 3 and Figure 1). A paired t-test was carried out
in order to examine between which time points the greatest change
occurred. Results indicate that the greatest reduction occurred
between time 1 (pre-consultation) and time 2 (short term follow
up) (t(186)=7.18, P50.0001) with a further smaller reduction from
time 2 to the 6 month follow up (t(186)=2.59, P50.01). This was
sustained until 12 months follow up with no significant further
decrease (t(186)=0.82, ns). There was no group effect or interaction
effect on this measure.
Worry about ovarian cancer No significant changes occurred
over the 12 month study period in level of worry about develop-
ing ovarian cancer. There were, however, significant group
differences. A post hoc test (least significant difference, P50.05)
showed that affected women were significantly more worried than
women at moderate and high risk about developing ovarian
cancer. Low risk women did not differ from the other groups
(Table 4).
Perceived risk No significant changes occurred in levels of
perceived risk over the study period. However, the groups of
women did differ. A post hoc test revealed that low risk women
perceived themselves to be less at risk than did all other groups.
In addition, moderate risk women felt less at risk than did high
risk women (Table 4).
Perceived likelihood of carrying a mutation Over the course of
the study significant changes occurred in perceptions of the likeli-
hood of carrying a mutation (Table 3). Paired t-tests showed that
for the sample as a whole the greatest reduction in perceived like-
lihood occurred between time 1 and 2 (t(175)=2.95, P50.01), with
no significant reduction occurring between times 2 and 3
(t(175)=1.79, ns) or 3 and 4 (t(175)=1.01, ns). In addition, groups
differed on this measure. Post hoc tests revealed that women at
low or moderate risk felt it was less likely that they carried a muta-
tion than did women at high risk or affected women (Table 4).
However, interpretation of these time and group effects needs to
be qualified in light of the significant interaction between time
and group found for this variable (Table 3). Individual ANOVAs
were carried out for each group to confirm that significant changes
occurred over time for perceived likelihood of carrying a genetic
mutation. Each ANOVA was significant (low risk F=8.62,
P50.001; moderate risk F=4.96, P50.01; high risk F=4.25,
P50.01; affected women F=4.13, P50.01). Post hoc paired t-tests
were then carried out for each group separately for changes in
perceived likelihood in order to clarify the pattern of changes seen
in Figure 2. Clearly, perceptions are higher among the high risk
and affected women in comparison with the low and moderate risk
women. The paired t-test results indicate that perceptions are fairly
stable among the low and moderate risk women over the course of
the study, whereas changes occur among high risk and affected
women. Perceptions of the likelihood of carrying a gene mutation
reduces for high risk women following the counselling session
(t(36)=2.95, P50.01), then significantly increases at 6 months post
consultation (t(36)=72.71, P50.01), and significantly decreases
again at 12 months post consultation (t(36)=1.87, P50.05). For
affected women, there is no immediate reduction in perceived like-
lihood (t(40)=0.00, ns), then a significant reduction at 6 months
post consultation (t(40)=3.42, P50.01), followed by a significant
increase in perceptions at 12 months post consultation
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(t(40)=72.48, P50.05). For low risk and moderate risk women,
other than a significant reduction following counselling for low risk
women (t(23)=2.81, P50.01), perceptions remain stable. For low
risk women there is no change at 6 months (t(23)=0.00, ns) or
12 months (t(23)=1.81, ns). For moderate risk women there is no
change immediately after counselling (t(73)=1.00, ns), at 6 months
(t(73)=1.54, ns), or 12 months (t(73)=1.59, ns). Therefore, although
there is enough overall change for the ANOVA to be statistically
significant for these two groups (low and moderate risk women),
when the pairwise t-tests are carried out it can be seen that the
individual change between time points is small or, indeed, insignif-
icant.
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Table 3 Results of repeated measures analyses of variance examining changes
following genetic counselling and group differencesa
Measures Time effect Groups effect Group6time
HADS anxiety F(3,182)=2.10, ns F(3,182)=1.78, ns F(9,182)=0.71, ns
HADS depression F(3,182)=0.92, ns F(3,182)=2.45, ns F(9,182)=1.30, ns
STAI scale F(3,160)=1.47, ns F(3,160)=0.46, ns F(9,160)=1.42, ns
GHQ-28 F(3,150)=2.45, ns F(3,150)=1.09, ns F(9,150)=0.80, ns
Breast cancer worry F(3,183)=38.04** F(3,183)=0.21, ns F(9,183)=1.24, ns
Ovarian cancer worry F(3,168)=1.51, ns F(3,168)=5.83* F(9,168)=0.59, ns
Risk perceptions F(3,177))=1.72, ns F(3,177)=8.46** F(9,177)=1.29, ns
Perceived likelihood of mutation F(3,172)=12.89** F(3,172)=10.72** F(9,172)=3.34*
aSample sizes vary due to missing data. *P50.01; **P50.0001.
Table 2 Group means (s.d.s) for psychological variables at each time point
Time 1 Time 2 Time 3 Time 4
Measures Mean (s.d.)
HADS anxiety (n=186)
Low risk (n=24) 7.5 (4.4) 7.8 (4.5) 7.6 (4.1) 7.9 (5.0)
Moderate risk (n=74) 6.9 (3.8) 6.2 (3.5) 5.7 (3.9) 5.7 (3.9)
High risk (n=44) 6.1 (3.9) 5.9 (4.4) 5.4 (4.3) 5.3 (4.5)
Affected (n=44) 6.5 (4.1) 6.1 (3.4) 5.9 (4.2) 6.2 (4.4)
HADS depression (n=186)
Low risk (n=25) 3.8 (3.2) 3.4 (3.5) 3.6 (3.3) 4.6 (5.1)
Moderate risk (n=75) 2.8 (2.8) 2.8 (2.8) 2.9 (3.0) 2.6 (2.7)
High risk (n=43) 2.2 (3.3) 2.4 (3.2) 2.2 (3.9) 2.1 (3.4)
Affected (n=43) 3.3 (3.0) 3.0 (3.0) 3.1 (3.9) 3.6 (3.8)
STAI scale (n=164)
Low risk (n=19) 11.1 (3.8) 11.7 (4.5) 10.9 (4.9) 12.1 (5.6)
Moderate risk (n=66) 10.9 (3.9) 10.2 (3.2) 10.2 (3.8) 10.9 (3.4)
High risk (n=41) 11.7 (3.9) 10.1 (3.8) 10.8 (3.8) 9.9 (3.9)
Affected (n=38) 10.9 (4.6) 10.1 (3.1) 10.8 (3.9) 10.2 (3.4)
GHQ-28 (n=154)
Low risk (n=22) 24.7 (11.9) 21.4 (10.7) 22.7 (9.9) 23.9 (13.8)
Moderate risk (n=58) 20.8 (11.0) 19.2 (9.8) 17.7 (9.9) 18.8 (8.9)
High risk (n=38) 20.2 (11.7) 19.4 (12.5) 18.5 (11.6) 18.3 (12.6)
Affected (n=36) 21.3 (11.6) 18.3 (10.6) 21.2 (13.4) 20.7 (10.8)
Breast cancer worry (n=187)
Low risk (n=26) 12.5 (2.6) 10.8 (2.6) 10.4 (3.1) 10.3 (3.0)
Moderate risk (n=71) 12.4 (3.1) 11.0 (3.1) 10.3 (2.9) 10.6 (3.0)
High risk (n=46) 12.6 (3.2) 11.0 (3.6) 10.7 (2.4) 10.4 (2.8)
Affected (n=44) 12.1 (4.1) 11.6 (3.7) 11.3 (3.2) 10.7 (3.4)
Ovarian cancer worry (n=172)
Low risk (n=23) 8.1 (2.3) 8.1 (2.6) 8.1 (2.5) 8.3 (3.1)
Moderate risk (n=69) 7.6 (2.9) 7.2 (1.8) 7.2 (1.8) 7.3 (1.9)
High risk (n=43) 8.2 (2.4) 7.9 (2.1) 7.8 (2.0) 7.9 (1.9)
Affected (n=37) 9.1 (3.5) 8.6 (2.6) 8.9 (3.5) 9.5 (3.3)
Risk perceptions (n=181)
Low risk (n=25) 0.8 (0.7) 0.4 (0.6) 0.6 (0.7) 0.6 (0.6)
Moderate risk (n=73) 1.2 (0.7) 1.1 (0.7) 1.0 (0.8) 1.1 (0.6)
High risk (n=41) 1.3 (0.7) 1.4 (0.7) 1.3 (0.8) 1.4 (0.7)
Affected (n=42) 1.2 (0.9) 1.3 (0.8) 1.2 (1.0) 1.0 (1.1)
Perceived likelihood of mutation (n=176)
Low risk (n=24) 0.6 (0.6) 0.4 (0.9) 0.4 (0.8) 0.2 (0.8)
Moderate risk (n=74) 0.5 (0.8) 0.4 (0.7) 0.3 (0.8) 0.2 (0.9)
High risk (n=37) 1.1 (0.8) 0.7 (0.7) 1.0 (0.7) 0.8 (0.7)
Affected (n=41) 0.9 (0.9) 0.9 (0.9) 0.4 (0.8) 0.8 (0.8)
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DISCUSSION
This prospective study enabled changes in psychological distress,
worry and perceptions of risk to be assessed over the course of 1
year among women at differing levels of objective risk. Prior to
attending for genetic counselling, women did not have raised levels
of general psychological distress, anxiety or depression in compar-
ison to other women attending for counselling or breast screening.
However, on the whole they were worried about developing breast
cancer, perceived themselves to be at greater risk of breast cancer
than other women their age and felt that it was likely that they
carried a mutation that would increase their risk of developing
cancer. Women who had already had, and been treated for, cancer
were found to be particularly worried about developing ovarian
cancer and perceived the likelihood of them carrying a genetic
mutation to be high.
Changes following counselling
There was no evidence found in this study that genetic counselling
raises worry. Levels of worry about developing breast cancer in fact
reduced following genetic counselling, regardless of what risk
women had been given. The greatest reduction in worry occurred
immediately after counselling, suggesting that the counselling had
a positive influence rather than it simply being the passage of time
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Table 4 Group differences
Low risk Moderate risk High risk Affected
(1) (2) (3) (4)
Measure mean (s.d.) Comparisons
Ovarian cancer worry 8.2 (2.48) 7.4 (1.57) 8.1 (1.9) 8.8 (2.7) 2, 354
Risk perceptions 0.6 (0.46) 1.1 (0.54) 1.3 (0.51) 1.2 (0.76) 152, 3, 4
253
Perceived likelihood of a mutation 0.1 (0.58) 0.4 (0.65) 0.9 (0.59) 0.8 (0.70) 1, 253, 4
13
12.5
12
11.5
11
10.5
10
low risk
moderate risk
high risk
affected
pre-con 2 weeks 6 months 12 months
Figure 1 Changes in worry about breast cancer.
1.1
0.9
0.7
0.5
0.3
0.1
-0.1
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Figure 2 Interaction between time and group effects for likelihood of carrying a mutation.
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that lead to a reduction in worry. Brain et al (2000b) also found
that a reduction in worry about breast cancer was largest straight
after a genetic counselling consultation. This positive effect of
counselling was sustained in the long term with worry not signifi-
cantly increasing, and remaining lower than at pre-consultation 12
months later. This finding is reassuring as one might expect worry
to increase after counselling especially amongst the higher risk
groups once women had been told about their risk. This reduction
in specific worry highlights the importance of including an exam-
ination of cancer specific measures of anxiety and worry as no
changes were found on any of the standard measures of general
anxiety and distress. This finding is in contrast to previous research
(Cull et al, 1999; Brain et al, 2000a) which found a reduction in
general distress.
The study allowed for a comparison between levels of worry
about developing breast and ovarian cancer. Stark differences were
found, with worry being much greater about developing breast
cancer. There were no changes in the level of worry about develop-
ing ovarian cancer over the course of the study which may be
because level of worry was fairly low at the outset (although higher
in affected women than other groups), perhaps due to the rarer
nature of ovarian cancer and it receiving less media coverage. It
is worth noting, however, that if a mutation is found in a woman,
although ovarian cancer is less likely to develop than breast cancer,
in relation to population risk it is markedly increased and perhaps
worry is therefore unrealistically low.
Prior to their consultation, taking into account the rarity of
BRCA1 and BRCA2 mutations, the sample of women as a whole
grossly overestimated their likely chances of being a mutation
carrier. However, following the genetic counselling session percep-
tions of the likelihood reduced most markedly. There was a
significant interaction between time and group for this variable
and therefore changes over time cannot be interpreted separately
from group. For affected women there was a significant decrease
in perceived likelihood at 6 months. This is likely to be due to
37 of these women receiving an ‘inconclusive’ result stating that
two thirds of the BRCA1 gene had been searched and no mutation
had been found and that the remaining third and all of BRCA2
would be searched. A study examining the interpretation of such
results has been prepared for publication (Bish et al, 2001). This
study indicates that whilst the result is in fact inconclusive it is
actually interpreted by most women in a positive light as indicating
that no mutation is present. At 12 months post consultation there
is a significant increase in perceived likelihood again, perhaps as
the time since the inconclusive result has passed and anxieties
begin to increase towards pre interim result levels. For high risk
women perceptions of the likelihood of carrying a genetic mutation
actually increase at 6 months post consultation, which may be due
to the lack of genetic testing available to most of these women at
the present time and therefore their concerns over their risk are not
alleviated. Low and moderate risk women show little change in
perceptions, which started low and remained so following counsel-
ling. The findings concerning this variable would need to be
replicated in view of the fact that only one item was used to assess
perceived likelihood and therefore the measure has unestablished
reliability. The pattern of change in the different risk groups is,
however, interesting.
It was of interest to note that whilst worry about developing
breast cancer reduced there was no change in perceptions of risk
of developing this cancer, despite some women being told that
their risk was low. This may be because women were reasonably
realistic at the outset – those at greater risk felt more at risk. This
result is in line with that found in some previous research (e.g.
Leggatt et al, 2000). The finding may also be due to the way in
which the variable was operationalized in this study where a broad
base of comparison with other women was taken rather than a
more specific estimate of accuracy in relation to an objective assess-
ment. Hence women may seemingly be more ‘realistic’. The
discussion of surveillance options during the consultation may
have made women feel they could do something to reduce their
risk, so whilst perceived risk remained the same, women were less
worried. It is possible however that the measure used to assess risk
was insufficiently sensitive to detect any changes since only one
item assessed risk perceptions and the reliability of this measure
is unknown.
Group differences
To our knowledge the current study is the only prospective study
of psychological impact of genetic counselling to include previously
affected women. Affected women form a significant minority of
those women being seen and the majority of those undergoing
genetic testing at present. Their inclusion in psychological impact
studies is therefore very important. The results of the current study
have implications for practice as they show that affected women
need the same level of counselling as unaffected women and that
having already had cancer does not mean that the issues have been
dealt with and that concerns will be fewer. For example, affected
women were more worried than moderate or high risk women
about developing ovarian cancer. In addition, as detailed above,
the pattern of change in perceptions of likelihood show that
affected women are influenced by the consultation and perceive
themselves to be at, arguably, unrealistically high risk of carrying
a genetic mutation.
Regarding differences between groups for risk perceptions and
perceived likelihood of carrying a mutation, these were generally
in line with reality – those at less risk felt at less risk. The findings
are in contrast to previous research by Cull et al (1999) who found
that a significant proportion of the women in their study contin-
ued to be inaccurate in their perceptions following counselling,
even when they had been informed that their risk was low.
It is reassuring that the discussion of inherited breast and ovarian
cancer did not appreciably raise anxieties in the low risk group. These
women felt less at risk than other groups before counselling and after-
wards. However, these women were equally as worried about
developing breast or ovarian cancer as the other groups, and although
their worry about breast cancer reduced it did not reduce any more
than in the other groups. These low risk women may therefore consti-
tute a group of ‘worried well’. It can be argued that their management
would be more appropriate at the primary care level.
Limitations of the study
One limitation of the current study is that it was based in only one
clinic therefore the sample is fairly small, which may affect the
generalisability of the results. The findings therefore need to be
replicated in other clinics with different counsellors. In addition,
it was not possible to follow up every woman who attended the
clinic and began to participate in the research for the full 12
months. The finding that those with incomplete data were younger
is in line with that found by Brain et al (2000b). It could be argued
that the prospect of being at risk of developing cancer at a young
age is too distressing for the younger women for whom it is less
common among their peers. For example, Codori et al (1997)
found that highly anxious individuals avoid risk information.
However, as there were no psychological differences between
groups this is unlikely to be the case. There is no evidence that
the most anxious women dropped out of the study. In fact, the
women participating in the research are representative of attenders
at the clinics as the response rates to the questionnaires are good
(over 83% for each questionnaire). A higher proportion of women
in the affected group did not have complete data. The affected
women included in the analyses in this study were those who
had been sent an appointment, whereas many affected women
attend the clinic with an unaffected relative and are counselled at
this stage and may undergo genetic testing. Results from data
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collected from such women are included in the study by (Bish et al,
submitted).
Past psychiatric history or use of psychotropic medication was
not assessed. There is, however, no reason to suppose that these
factors would systematically vary by group.
Conclusion
In conclusion, then, specific worry about developing breast cancer
was reduced for all groups following genetic counselling, although
perceptions of risk did not change. Counselling had no impact on
general levels of distress, which were not, however, appreciably
raised before counselling. On the whole, women who have already
had cancer showed raised levels of concern about developing ovar-
ian cancer and felt more at risk of developing breast cancer and of
having a mutation, in comparison with other groups. This indi-
cates the need for sensitive counselling of such women.
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